193 related articles for article (PubMed ID: 23197043)
1. Increased protein kinase A type Iα regulatory subunit expression in parathyroid gland adenomas of patients with primary hyperparathyroidism.
Hibi Y; Kambe F; Imai T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Ito A; Iwase K
Endocr J; 2013; 60(2):215-23. PubMed ID: 23197043
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of the gene encoding protein kinase A type I alpha regulatory subunit in nodular hyperplasia of parathyroid glands in patients with chronic renal failure.
Hibi Y; Kambe F; Tominaga Y; Mizuno Y; Kobayashi H; Iwase K; Imai T; Seo H
J Clin Endocrinol Metab; 2006 Feb; 91(2):563-8. PubMed ID: 16303839
[TBL] [Abstract][Full Text] [Related]
3. Morphological evaluation of parathyroid adenomas and immunohistochemical analysis of PCNA and Ki-67 proliferation markers.
Demıralay E; Altaca G; Demırhan B
Turk Patoloji Derg; 2011; 27(3):215-20. PubMed ID: 21935871
[TBL] [Abstract][Full Text] [Related]
4. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
Yamaguchi S; Yachiku S; Morikawa M
J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
[TBL] [Abstract][Full Text] [Related]
5. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
[TBL] [Abstract][Full Text] [Related]
6. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.
Schmid KW; Hittmair A; Ladurner D; Sandbichler P; Gasser R; Tötsch M
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):295-9. PubMed ID: 2024450
[TBL] [Abstract][Full Text] [Related]
8. Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity.
Loda M; Lipman J; Cukor B; Bur M; Kwan P; DeLellis RA
Hum Pathol; 1994 Oct; 25(10):1050-6. PubMed ID: 7927309
[TBL] [Abstract][Full Text] [Related]
9. Selected markers of proliferation and apoptosis in the parathyroid lesions: a spatial visualization and quantification.
Kaczmarek E; Lacka K; Majewski P; Trzeciak P; Gorna A; Jarmolowska-Jurczyszyn D; Kluk A
J Mol Histol; 2008 Oct; 39(5):509-17. PubMed ID: 18726191
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone immunohistochemistry in dogs with primary and secondary hyperparathyroidism: the question of adenoma and primary hyperplasia.
van Vonderen IK; Kooistra HS; Peeters ME; Rijnberk A; van den Ingh TS
J Comp Pathol; 2003 Jul; 129(1):61-9. PubMed ID: 12859909
[TBL] [Abstract][Full Text] [Related]
11. Oxyphilic cell adenoma of parathyroid resulting in primary hyperparathyroidism and osteitis fibrosa cystica--a case report.
Prasad KK; Agarwal G; Mishra SK; Krishnani N
Indian J Pathol Microbiol; 2006 Jul; 49(3):448-50. PubMed ID: 17001919
[TBL] [Abstract][Full Text] [Related]
12. [Study on the cellular proliferation and endocrine activity of the parathyroid gland in hyperparathyroidism].
Hosokawa S
Nihon Hinyokika Gakkai Zasshi; 1993 Aug; 84(8):1424-31. PubMed ID: 8411803
[TBL] [Abstract][Full Text] [Related]
13. The role of hyperplasia in multiple parathyroid adenomas.
Larian B; Alavi S; Roesler J; Namazie A; Blackwell K; Calcaterra TC; Wang MB
Head Neck; 2001 Feb; 23(2):134-9. PubMed ID: 11303630
[TBL] [Abstract][Full Text] [Related]
14. Adrenomedullin immunoreactivity tissue distribution in parathyroids of the patients with primary hyperparathyroidism.
Letizia C; Ricci F; De Toma G; Cianci R; Alo P; Celi M; Panzironi G; Mingazzini PL; D'Erasmo E; Mazzuoli GF
Horm Metab Res; 2004 Jul; 36(7):480-4. PubMed ID: 15305232
[TBL] [Abstract][Full Text] [Related]
15. Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules.
Tanaka R; Umemura S; Kakuta T; Fujisaki T; Sakai H; Saitoh A; Osamura RY
Pathol Res Pract; 2003; 199(2):93-9. PubMed ID: 12747471
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism.
Szende B; Farid P; Végso G; Perner F; Kopper L
Pathol Oncol Res; 2004; 10(2):98-103. PubMed ID: 15188026
[TBL] [Abstract][Full Text] [Related]
17. Oxyphil Cell Parathyroid Adenomas Causing Primary Hyperparathyroidism: a Clinico-Pathological Correlation.
Howson P; Kruijff S; Aniss A; Pennington T; Gill AJ; Dodds T; Delbridge LW; Sidhu SB; Sywak MS
Endocr Pathol; 2015 Sep; 26(3):250-4. PubMed ID: 26091632
[TBL] [Abstract][Full Text] [Related]
18. Nonautonomy of parathyroid hormone and urinary cyclic AMP in primary hyperparathyroidism.
Monchik JM; Wray HL; Schaaf M; Earll JM
Am J Surg; 1977 Apr; 133(4):498-505. PubMed ID: 192097
[TBL] [Abstract][Full Text] [Related]
19. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the int-2 gene product in primary and secondary parathyroid lesions.
Tseleni-Balafouta S; Thomopoulou G; Lazaris ACh; Koutselini H; Davaris PS
Eur J Endocrinol; 2002 Jan; 146(1):57-60. PubMed ID: 11751068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]